What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a… bypharmanewsdailyAugust 11, 2020